pillbase.ru

Briumvi

Active substance: ublituximab

ublituximab

Centralised EU authorisationActive

Marketing holder: Neuraxpharm Pharmaceuticals S.L.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 1
  • BRIUMVI
    INJECTION, SOLUTION, CONCENTRATE · UBLITUXIMAB 150 mg/6mL
    73150-150
    TG Therapeutics, Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1209c-1a0c-7364-b1d0-e8f1d235e8e5;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/005914
Registration status
Active
ATC code
L04
Sources
  • product · EMA · EMEA/H/C/005914 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/005914 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/005914 · Verified 2026-10-09